简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
Notice of Approval for Clinical Trials
HENGRUI PHARMA (01276.HK): Five Innovative Drugs Obtain Clinical Trial Approvals, Targeting KRAS G12D and Other Indications
Tags：
HENGRUI PHARMA
01276.HK
Notice of Approval for Clinical Trials
2026-05-09
HENGRUI PHARMA(01276.HK): HRS-3005 Tablets Granted Clinical Trial Approval for B-Cell Malignancies
Tags：
HENGRUI PHARMA
01276.HK
Notice of Approval for Clinical Trials
2026-05-09
Featured News
Finance
Jiangxi Institute of Biological Products Inc.(06915.HK): Subsidiary Obtains Approval Number for Veterinary Tetanus Antitoxin
Finance
Brii Biosciences (02137.HK): Releases End-of-Treatment Topline Data from Phase 2b Chronic Hepatitis B Studies
Finance
51World (06651.HK): Placing New H Shares Under General Mandate
Finance
China Power (02380.HK): Signs Desulfurization Project Contract Worth About RMB 220 Million, Constitutes Connected Transaction
Finance
FriendTimes (06820.HK): Controlling Shareholder Purchases 1.23 Million Shares, Stake Rises to 57.43%
Finance
Fudan-Zhangjiang (01349.HK): Invests RMB 330 Million in Structured Deposits of Ping An Bank
Finance
Autonomous Driving Concept Stocks Watch | Higher Entry Barriers for Advanced Autonomous Driving Industry Under New Regulations; BIDU-SW(09888.HK) Edges Upward in Afternoon Trading
Finance
Insilico Medicine (03696.HK): Strategic Partnership with Takeda for AI-Driven Drug Discovery with Total Value Up to USD 600 Million
Finance
MANYCORE TECH (00068.HK): Grant of 1,130,000 Restricted Share Units to 24 Employees
Finance
People's Insurance Company of China Group (01339.HK): Appointment Qualification of Vice President Zhang Daoming Approved by the State Administration of Financial Regulation
Scan QR Code
Download App
